Navigation Links
The importance of standardizing drug screening studies
Date:12/2/2013

Montral, December 2, 2013 A bioinformatics expert at the IRCM, Benjamin Haibe-Kains, recently published an article stressing the importance of standardizing drug screening studies in the prestigious scientific journal Nature. The study supports the need for further development and standardization to improve the reproducibility of drug screening studies, as they are important in identifying new therapeutic agents and their potential combinations with existing drugs.

Dr. Haibe-Kains's article investigated results from two large-scale pharmacogenomic studies the Cancer Genome Project (CGP) and the Cancer Cell Line Encyclopedia (CCLE) published last year in Nature. The main goal of these studies was to identify genomic biomarkers that could predict patients' response to anticancer drugs. Because cancer patients often exhibit varied responses to anticancer treatments, and evidence indicates that response is determined in part by patient-specific genome alterations, cancer cell line studies have long been used to test the efficacy of therapeutic agents and explore genomic factors associated with drug response. These two studies screened multiple new and approved drugs on nearly 1,000 panels of cancer cell lines, of which 15 drugs and 471 cell lines were common.

"These studies provided us with a unique opportunity to look at the reproducibility of biomarker discovery in preclinical settings," says Dr. Haibe-Kains, Director of the Bioinformatics and Computational Biology research unit at the IRCM. "Our objective was to examine the uniformities and inconsistencies between results from the two independent studies, and assess the potential of building predictive models of drug response on the basis of those results."

Dr. Haibe-Kains and his research team observed overall good consistency of genomic profiles, which contain information about all the genes in the body and can be used to determine response to a drug. However, drug sensitivity measurements used in the two studies were highly inconsistent.

"We believe the reasons for such differences include the lack of standardization in experimental assays and data analysis methods," adds Dr. Haibe-Kains. "For example, the studies tested different drug concentrations and used different statistical models to analyze their data. In addition, due to discrepancies in drug sensitivity data, some potential biomarkers were inconsistent between the two studies."

"These pharmacogenomic studies are generally the first step in a larger experimental pipeline where candidate drugs and biomarkers are further validated in animal studies and human clinical trials," explains Dr. Haibe-Kains. "Our findings support the need for standardization of drug-response measurements or the development of new, robust drug sensitivity assays in order to identify reliable genomic predictors of drug response or effectively identify a drug's mechanism of action."

"It is important to note that our study and the resulting observations could not have been possible if the data had not been well documented and made accessible to the scientific community," concludes Dr. Haibe-Kains. "This represents a big success for open data science and reproducible research, and we would like to thank the investigators from the CGP and CCLE studies who made their invaluable data available to researchers everywhere. Without this data, we would not have been able to discover the discrepancies. We now need to work together to improve the reproducibility of large-scale screening studies so that we can identify new therapeutic agents and their potential combinations with existing drugs."


'/>"/>

Contact: Julie Langelier
julie.langelier@ircm.qc.ca
514-987-5555
Institut de recherches cliniques de Montreal
Source:Eurekalert

Related medicine news :

1. ATCC Examined the Importance of High-quality Controls in Assay Design and Development During the Association for Molecular Pathology (AMP) 2013 Annual Meeting
2. Online Insurance Marketplace Explains the Importance of Talking with Parents About Life Insurance
3. CHAMPS to Host Complimentary Webinar on the Importance of Patient Experience Strategy
4. IBWA Video Highlights Importance of Having Bottled Water as a Choice
5. Flavor Your Life Discusses the Importance of Olive Oil Classification and How It Helps Determine the Characteristics of Products Like Tuscan Olive Oil
6. Nuvora, Inc., Creators of Salese, Helps Spread Awareness of the Importance of Good Oral Care for Diabetics
7. ServiceMaster by Singer Raising Awareness about Lung Cancer Awareness Month, the Development of Treatments and the Importance of Quitting Smoking
8. Importance of Managing Insulin Resistance Discussed in New Video By Health Nutrition News
9. My Positive Perspective Broadcasts Episode on the Importance of Teamwork and Cooperation in the Development of Youth
10. Hosted by Jimmy Johnson, "Leading Edge" Will Discuss the Importance of Disaster Preparedness
11. The YMCA and Carowinds Team Up to Reinforce the Importance of Learning to Swim and Reward Kids for Practicing Water Safety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 27, 2016 , ... A revolution is underway. Brooklyn-based ... experience for the millions of people who require these medical transport services annually. ... through the use of technology. Now, SmartEMS has put forth an industry-changing app ...
(Date:6/26/2016)... PLAINSBORO, N.J. (PRWEB) , ... June 27, 2016 , ... ... same sources, yet in many ways they remain in the eye of the beholder, ... Oncology (EBO), a publication of The American Journal of Managed Care. For the full ...
(Date:6/26/2016)... ... , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... a whole new perspective by using the title layers in ProSlice Levels to ... ProSlice Levels contains over 30 Different presets to choose from. FCPX users ...
(Date:6/26/2016)... , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal ... personalized through a fitness app. The fitness app plans to fix the two major problems ... offer a one size fits all type program , They don’t eliminate all ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American Institutes ... Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , ... advance care planning, healthcare costs and patient and family engagement. , AIR researchers ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Bay ... Rehabilitation Network,s Dean Center for Tick Borne ... Medicine and Rehabilitation, MIT Hacking Medicine, University of ... Innovation, today announced the five finalists of ... Lyme disease.  More than 100 scientists, clinicians, researchers, ...
(Date:6/24/2016)... , June 24, 2016 ... the "Structural Electronics 2015-2025: Applications, Technologies, Forecasts" ... In-Mold Electronics, Smart Skin, Structural ... Structural electronics involves electronic and/or ... protective structures, replacing dumb structures such as vehicle ...
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical Systems ... "Company"), which develops, markets and sells medical devices and ... , signed a strategic cooperation agreement with Hongyuan Supply ... Supply Chain") on June 20, 2016, to develop Dehaier,s ... strategic cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s ...
Breaking Medicine Technology: